Ancillare is the first and only Life Sciences company dedicated to Clinical Trial Ancillary Supply Chain (CTASC) for Phase I-IV clinical research. Ancillare arms Sponsors of global clinical trials with customised, end-to-end supply plans, enabling developers of new therapies to optimise their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare’s industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain.

Services include:
– Clinical Supply Management
– Clinical Trials Management
– Clinical Trials
– Supply Chain Management

With nearly 15 years of experience, Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites in over 100 countries. To learn more, visit ancillare.com.